首页> 外文期刊>Journal of Drug Delivery and Therapeutics >Drug Utilization Evaluation of Metronidazole at a Tertiary Care Center in Hyderabad, India
【24h】

Drug Utilization Evaluation of Metronidazole at a Tertiary Care Center in Hyderabad, India

机译:印度海得拉巴三级护理中心对甲硝唑的药物利用评估

获取原文
           

摘要

Drug use evaluation is an on-going, systematic, criteria-based program of medicine evaluations that will help ensure appropriate medicine use. If therapy is determined to be inappropriate, interventions with providers or patients will be necessary to optimize pharmaceutical therapy. In our study we have developed a data collection form based upon WHO guidelines for conducting a DUE study on metronidazole use evaluation. To assess the usage of metronidazole at a tertiary care center Hyderabad a retrospective evaluation of usage patterns was carried out for the period of 6 months corresponding to the dates to 1-1-2018 to 30-6-2018. For conducting the evaluation process we had followed the standard guide lines formulated by WHO. The gender distribution of case sheets were male- 69, female- 80. Indication wise the distribution of case sheets were -43.23% are prophylaxis and surgical prophylaxis, 32.81% are non-indicated and 18, 96% were given for infections. The minimum number of days of treatment was 1 day and the maximum number of days of treatment was 23 days. All patient folders evaluated with regards to cellulitis, gynaecological surgeries, UTI, LRTI etc were found to meet the standard criteria appropriate for metronidazole use with respect to dose, and dose frequency. However, in the case of duration the evaluation was found to be largely inappropriate for all the justified indications. In addition, 34.81% of metronidazole use for unjustified indications was noted. This means that metronidazole has been deviated from standard treatment guidelines hence it facilitates the development of resistant strains to metronidazole and of no use in the near future, and it also affect the patient economically.
机译:药物使用评估是一项持续的,系统的,基于标准的药物评估计划,有助于确保适当的药物使用。如果确定治疗不合适,则必须对提供者或患者进行干预以优化药物治疗。在我们的研究中,我们根据WHO指南开发了数据收集表,以进行甲硝唑使用评估的DUE研究。为了评估在海得拉巴三级护理中心使用甲硝唑的情况,我们对6个月的使用模式进行了回顾性评估,对应的日期为2018年1月1日至2018年6月30日。为了进行评估,我们遵循了世界卫生组织制定的标准指南。病例表的性别分布是男性-69,女性-80。指示上病例表的分布为-43.23%为预防和手术预防,32.81%为未指示,18、96%为感染。最小治疗天数为1天,最大治疗天数为23天。发现所有有关蜂窝组织炎,妇科手术,UTI,LRTI等评估的患者资料夹均符合甲硝唑使用的剂量和剂量频率标准标准。但是,在持续时间的情况下,发现评估对于所有合理的适应症都不合适。此外,注意到甲硝唑的34.81%用于不合理的适应症。这意味着甲硝唑已经偏离了标准治疗准则,因此它促进了对甲硝唑的耐药菌株的开发,并且在不久的将来不再使用,并且还对患者产生了经济影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号